Mild High-Renin Essential Hypertension
Murray Esler(Baker Heart and Diabetes Institute), Vincent DeQuattro(Baker Engineering (United States)), Hermsworth Gardiner(Baker Engineering (United States)), Andrew J. Zweifler(Baker Engineering (United States)), Stevo Julius, Ernest Harburg(Baker Engineering (United States)), Otelio S. Randall(Baker Engineering (United States))
Cited by 536
Related Papers
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
|The Lancet|1998|5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
|The Lancet|2010|2.2k